Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q2 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) is further expanding its no-charge COVID-19 testing capabilities with 99 additional drive-through locations opening on Tuesday, December 22 through its partnership with the U.S. Department of Health and Human Services (HHS). Rite Aid's COVID-19 testing service will expand coast-to-coast, with new locations in California, Nevada, Washington, Michigan, Ohio, Pennsylvania, Virginia, New York, Connecticut, New Jersey, Delaware, and Maryland. Lik

Rite Aid Expands No-Charge COVID-19 Testing to 400 Drive-Through Locations

Rite Aid's (RAD) Q3 results gain from solid demand, rise in same-store prescription count, strength in Elixir brand and robust online growth. Also, it is progressing well with RxEvolution strategy.

Rite Aid (RAD) Soars on Earnings & Revenues Beat in Q3

The coronavirus didn't exactly have a damaging effect on the pharmacy chain.

Rite Aid Posts Surprise Q3 Profit

Seeking Alpha Transcripts | Services Rite Aid Corporation (RAD) CEO Heyward Donigan on Q3 2021 Results - Earnings Call Transcript Dec. 17, 2020 1:31 PM ET | | About: Rite Aid Corporation (RAD) by: SA Transcripts Subscribers Only Earning Call Audio Rite Aid Corporation (NYSE:RAD) Q3 2021 Earnings Conference Call December 17, 2020 8:30 AM ET Company Participants Trent Kruse - VP of IR and Treasury Heyward Donigan - CEO

Rite Aid Corporation (RAD) CEO Heyward Donigan on Q3 2021 Results - Earnings Call Transcript

Lennar

Markets are climbing, and earnings reports from these companies have a lot to do with it.

These 2 Stocks Have Stock Market Investors Excited About 2021

Rite Aid Corporation reported on Thursday (Dec. 17) as part of its Fiscal 2021 Q3 results that revenues rose 12 percent, fueled by expansion in the retail pharmacy and pharmacy services areas. Revenues from continuing operations for the timeframe were $6.12 billion, up from $5.46 billion in the past year's quarter, according to an announcement.

Rite Aid Reports 12 Pct Rise In Revenues

The pharmacy company reported very good Q3 results.

Why Rite Aid Stock Is Rocking Today

Rite Aid Corp. is partnering with the Centers for Disease Control and Prevention in helping administer COVID-19 vaccines.

Rite Aid partners with CDC on COVID-19 vaccine as profits soar

RiteAid (RAD) is seeing an increase in RAD stock on Thursday following the release of the pharmacy company's fiscal Q3 2021 earnings report. The post RAD Stock: 14 Reasons Why RiteAid Is Rocketing Higher Today appeared first on InvestorPlace.

RAD Stock: 14 Reasons Why RiteAid Is Rocketing Higher Today

The shares of Rite Aid Corporation (NYSE:RAD) are surging, last seen up 25% to a new annual high of $21.39, after the pharmacy giant scored an unexpected quarterly profit.

Rite Aid Stock Soars to Annual High on Surprise Top-Line beat

Rite Aid (RAD) delivered earnings and revenue surprises of 4100.00% and 4.63%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?

Rite Aid (RAD) Tops Q3 Earnings and Revenue Estimates

Shares of Rite Aid Corp. soared 9.7% in premarket trading Thursday, after the drug store chain reported fiscal third-quarter profit and revenue that beat expectations, and raised its full-year outlook to expect earnings rather than potential losses. Net income for the quarter to Nov. 28 fell to $54.1 million, or 8 cents a share, from $53.6 million, or 96 cents a share, in the year-ago period.

Rite Aid's stock soars after big profit beat, raised outlook

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) today reported operating results for its third fiscal quarter ended November 28, 2020. For the third quarter, the company reported net income from continuing operations of $4.3 million, or $0.08 income per share, Adjusted net income from continuing operations of $21.6 million, or $0.40 income per share, and Adjusted EBITDA from continuing operations of $137.4 million, or 2.3 percent of revenues. “We are pleased with our third qua

Rite Aid Corporation Reports Fiscal 2021 Third Quarter Results

Baidu

DraftKings

General Mills

iQIYI

Baidu, iQiyi, DraftKings, Rite Aid and General Mills were our top stock trades for Thursday. That said, let's look at the charts now.

5 Top Stock Trades for Thursday: IQ, BIDU, DKNG, RAD, GIS

Strong performance in the retail pharmacy and pharmacy services segments is likely to have aided Rite Aid's (RAD) Q3 revenues. Also, solid demand for essentials has been driving performance.

Things You Must Know Ahead of Rite Aid's (RAD) Q3 Earnings

Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Rite Aid (RAD) Q3 Earnings Expected to Decline

Rite Aid (RAD) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

Rite Aid (RAD) Catches Eye: Stock Jumps 7.6%

CAMP HILL, Pa.--(BUSINESS WIRE)--Following this year's fundraising campaign, Rite Aid has exceeded $100 million in overall giving to Children's Miracle Network Hospitals.

Rite Aid Exceeds $100 Million in Overall Giving to Children's Miracle Network Hospitals

A number of factors, including a rebranding plan, lifted the stock in November.

Why Rite Aid Stock Jumped 44% Last Month

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2021 Third Quarter, which ended Nov. 28, 2020, on Thursday, Dec 17, 2020. The company will hold an analyst call at 8:30 a.m. Eastern Time with remarks by Rite Aid's management team. The call will be broadcast via the Internet at https://www.riteaid.com/corporate/investor-relations/presentations. The telephone replay will be available beginning at 12 p.m. Eastern Tim

Rite Aid to Release Third Quarter Results on December 17

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) has hired Texanna Reeves, a respected diversity and inclusion leader, to develop and implement the organization's overall diversity, inclusion and belonging strategy. Rite Aid has continued to hire senior leaders to drive forward its broader RxEvolution strategy, and the addition of Reeves signals the organization's commitment to sustainable systemic change as a key component of its overall transformation. “Diversity and inclusion are essent

Rite Aid Hires Texanna Reeves to Lead Diversity, Equity and Inclusion Efforts

Shares of Rite Aid Corp. were up 2.0% in trading on Tuesday after the government reportedly renewed funding for COVID-19 testing that had been set to expire at the end of this month. The drugstore chain had announced Tuesday morning that it would begin charging $115 for symptomatic and asymptomatic diagnostic testing starting Dec. 1.

Rite Aid's stock gains 2% as it says it will continue to offer free COVID-19 tests in December

CAMP HILL, Pa.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The updated release reads: RITE AID UPDATES COVID-19 TESTING PROGRAM Asymptomatic testing will be available for individuals 13 and older at existing Rite Aid testing sites To continue to provide its customers with an essential service during the pandemic, Rite Aid (NYSE: RAD) is updating its COVID-19 testing program through its partnership with the U.S. Department of Healt

CORRECTING and REPLACING Rite Aid Updates COVID-19 Testing Program

Rite Aid Corp. said Tuesday it will start charging $115 per COVID-19 test from Dec. 1, following the end of federal funding for diagnostic testing by the U.S. Department of Health and Human Services. The drug store chain said it will offer testing for individuals aged 13 and older regardless of whether they are symptomatic or asymptomatic.

Rite Aid to start charging $115 per COVID-19 test from Dec. 1 as federal funding ends

CAMP HILL, Pa.--(BUSINESS WIRE)--To continue to provide its customers with an essential service during the pandemic, Rite Aid (NYSE: RAD) is updating its COVID-19 testing program following the end of federal funding for diagnostic testing by the U.S. Department of Health and Human Services (HHS). Effective December 1, 2020, no-charge testing at Rite Aid's existing testing sites will be replaced by testing for individuals 13 years of age and older for $115 per test (payable via cash, credit, deb

News for Rite Aid Stock (RAD)